Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study

被引:19
作者
Faustini, Annunziata [1 ]
Hall, Andrew J. [2 ]
Mantovani, Jessica [3 ]
Sangalli, Massimo [1 ]
Perucci, Carlo A. [1 ]
机构
[1] Local Hlth Unit Agcy RME, Dept Epidemiol, I-00198 Rome, Italy
[2] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England
[3] Reg Agcy Publ Hlth, Dept Infect Dis, Rome, Italy
关键词
TB treatment outcomes; Medical record-linkage; Risk factors; Unsuccessful TB treatment; TB relapses;
D O I
10.1016/j.ijid.2007.12.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim of this study was to enhance tuberculosis (TB) treatment outcome monitoring by linking diverse surveillance systems and estimating treatment outcomes including relapse. Methods: Tuberculosis treatment was surveyed in the Lazio region (Italy) from 1999 to 2001; a sixyear follow-up of notified cases was undertaken to detect relapses. The results were analyzed as a population-based case-control study comparing each unsuccessful outcome and relapse with eligible controls. Results: Of the 974 patients who entered the survey, 805 (82.6%) had complete treatment evaluations; 398 (49.4%) had a successful outcome, 401 (49.8%) had an unsuccessful outcome, and six developed chronic TB. Death was associated with age >64 years (OR 5.9; 95% CI 3.1-11.2), mate gender (OR 2.1; 95% CI 1.0-4.4), and using second-line drugs (OR 2.3; 95% CI 1.0-5.4). Treatment failure was associated with previous treatment (OR 3.0; 95% CI 1.4-6.7) and being mate, being foreign born (OR 6.6; 95% CI 2.1-21.2), receiving second-tine drugs (OR 7.4; 95% CI 1.8-29.5), and receiving modified therapy (OR 5.1; 95% CI 1.7-14.9). Relapses after successful outcomes were detected in 5.5%, for which the strongest predictor was having extrapulmonary lesions (OR 22.8; 95% CI 1.8-287.3). Conclusions: Linking our survey data to other surveillance systems improved the mortality estimates and detected a high rate of relapse. Having received previous treatment and being a foreigner were independent determinants of treatment failure, suggesting that both acquired and primary drug resistance affect TB patients in Lazio. (C) 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:611 / 621
页数:11
相关论文
共 31 条
[1]  
[Anonymous], 2003, Treatment of tuberculosis: guidelines for national programmes, V3rd
[2]   Defaulting from tuberculosis treatment in the Netherlands: rates risk factors and trend in the period 1993-1997 [J].
Borgdorff, MW ;
Veen, J ;
Kalisvaart, NA ;
Broekmans, JF ;
Nagelkerke, NJD .
EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (02) :209-213
[3]   Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study [J].
Chiang, C-Y. ;
Enarson, D. A. ;
Yu, M-C. ;
Bai, K-J. ;
Huang, R-M. ;
Hsu, C-J. ;
Suo, J. ;
Lin, T-P. .
EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (05) :980-985
[4]   First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons [J].
Coninx, R ;
Mathieu, C ;
Debacker, M ;
Mirzoev, F ;
Ismaelov, A ;
de Haller, R ;
Meddings, DR .
LANCET, 1999, 353 (9157) :969-973
[5]   Tuberculosis recurrence and mortality after successful treatment:: Impact of drug resistance [J].
Cox, Helen ;
Kebede, Yared ;
Allamuratova, Sholpan ;
Ismailov, Gabit ;
Davletmuratova, Zamira ;
Byrnes, Graham ;
Stone, Christine ;
Niemann, Stefan ;
Ruesch-Gerdes, Sabine ;
Blok, Lucie ;
Doshetov, Daribay .
PLOS MEDICINE, 2006, 3 (10) :1836-1843
[6]  
Diel R, 2003, INT J TUBERC LUNG D, V7, P124
[7]  
Falzon D, 2006, Euro Surveill, V11, P20
[8]   Outcome of multi-drug-resistant tuberculosis in France - A nationwide case-control study [J].
Flament-Saillour, M ;
Robert, J ;
Jarlier, V ;
Grosset, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) :587-593
[9]   DNA fingerprint changes in tuberculosis: Reinfection, evolution, or laboratory error? [J].
Glynn, JR ;
Yates, MD ;
Crampin, AC ;
Ngwira, BM ;
Mwaungulu, FD ;
Black, GF ;
Chaguluka, SD ;
Mwafulirwa, DT ;
Floyd, S ;
Murphy, C ;
Drobniewski, FA ;
Fine, PEM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (06) :1158-1166
[10]   TREATMENT OF 171 PATIENTS WITH PULMONARY TUBERCULOSIS RESISTANT TO ISONIAZID AND RIFAMPIN [J].
GOBLE, M ;
ISEMAN, MD ;
MADSEN, LA ;
WAITE, D ;
ACKERSON, L ;
HORSBURGH, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :527-532